Journal
PHARMACEUTICALS
Volume 3, Issue 10, Pages 3343-3354Publisher
MDPI
DOI: 10.3390/ph3103343
Keywords
adenovirus; pharmaceuticals; microRNA
Categories
Funding
- Food and Health Bureau [RFCID- 08070082]
- Research Fund for the Control of Infectious Diseases of the Government of Hong Kong, SAR [RFCID- 08070082]
Ask authors/readers for more resources
There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A-F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
